Publicaciones en las que colabora con Enrique Morales Ruiz (11)

2024

  1. Detection of binucleated nephrin-marked podocytes by flow cytometry in the urine of patients with obesity

    Journal of Nephrology

  2. Renal Disease in Metabolic Syndrome: the Hidden Role of Intrarenal Ischemia

    Kidney International Reports, Vol. 9, Núm. 5, pp. 1419-1428

2023

  1. Consensus document of the Spanish Group for the Study of the Glomerular Diseases (GLOSEN) for the diagnosis and treatment of lupus nephritis

    Nefrologia, Vol. 43, Núm. 1, pp. 6-47

  2. Diagnosis and treatment of lupus nephritis: a summary of the Consensus Document of the Spanish Group for the Study of Glomerular Diseases (GLOSEN)

    Clinical Kidney Journal, Vol. 16, Núm. 9, pp. 1384-1402

2022

  1. Role of non-alcoholic fatty liver disease in the evolution of renal function in patients with diabetes mellitus

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 6, pp. 1125-1131

2021

  1. Renoprotective role of bariatric surgery in patients with established chronic kidney disease

    Clinical Kidney Journal, Vol. 14, Núm. 9, pp. 2037-2046

  2. The Role of Vascular Lesions in Diabetes Across a Spectrum of Clinical Kidney Disease

    Kidney International Reports, Vol. 6, Núm. 9, pp. 2392-2403

2020

  1. Erratum: SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA (Nephrology Dialysis Transplantation (2019) (gfy407) DOI: 10.1093/NDT/gfy407)

    Nephrology Dialysis Transplantation

  2. Erratum: SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA (Nephrology Dialysis Transplantation (2019) 34:2 (208–230) DOI:10.1093/ndt/gfy407)

    Nephrology Dialysis Transplantation

  3. The estimation of GFR and the adjustment for BSA in overweight and obesity: a dreadful combination of two errors

    International Journal of Obesity, Vol. 44, Núm. 5, pp. 1129-1140

2019

  1. SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA

    Nephrology Dialysis Transplantation, Vol. 34, Núm. 2, pp. 208-230